Published in J Exp Med on May 01, 1989
Characterization of genetically inactivated pertussis toxin mutants: candidates for a new vaccine against whooping cough. Infect Immun (1990) 1.44
Pertussis-specific cell-mediated immunity in infants after vaccination with a tricomponent acellular pertussis vaccine. Infect Immun (1996) 1.33
Lymphokine secretion and cytotoxic activity of human CD4+ T-cell clones against Bordetella pertussis. Infect Immun (1991) 1.31
Metabolic, humoral, and cellular responses in adult volunteers immunized with the genetically inactivated pertussis toxin mutant PT-9K/129G. J Exp Med (1990) 1.30
The T cell response of HLA-DR transgenic mice to human myelin basic protein and other antigens in the presence and absence of human CD4. J Exp Med (1995) 1.23
Recombinant Mycobacterium bovis BCG expressing pertussis toxin subunit S1 induces protection against an intracerebral challenge with live Bordetella pertussis in mice. Infect Immun (2000) 1.17
Interaction of the pertussis toxin peptide containing residues 30-42 with DR1 and the T-cell receptors of 12 human T-cell clones. Proc Natl Acad Sci U S A (1992) 1.12
Properties of pertussis toxin mutant PT-9K/129G after formaldehyde treatment. Infect Immun (1991) 1.09
Mucosal immunization with a genetically engineered pertussis toxin S1 fragment-cholera toxin subunit B chimeric protein. Infect Immun (2003) 1.05
Pertussis holotoxoid formed in vitro with a genetically deactivated S1 subunit. Proc Natl Acad Sci U S A (1989) 1.03
Neutralizing antibodies and immunoprotection against pertussis and tetanus obtained by use of a recombinant pertussis toxin-tetanus toxin fusion protein. Infect Immun (1994) 1.02
Surface expression of a protective recombinant pertussis toxin S1 subunit fragment in Streptococcus gordonii. Infect Immun (1999) 0.98
Purification and immunogenicity of a recombinant Bordetella pertussis S1S3FHA fusion protein expressed by Streptococcus gordonii. Appl Environ Microbiol (2002) 0.95
Identification of ricin A-chain HLA class II-restricted epitopes by human T-cell clones. Clin Exp Immunol (2001) 0.94
Formaldehyde treatment of proteins can constrain presentation to T cells by limiting antigen processing. Infect Immun (1994) 0.93
Substantial gaps in knowledge of Bordetella pertussis antibody and T cell epitopes relevant for natural immunity and vaccine efficacy. Hum Immunol (2014) 0.88
Identification of subregions of Bordetella pertussis filamentous hemagglutinin that stimulate human T-cell responses. Infect Immun (1991) 0.88
Loss of multi-epitope specificity in memory CD4(+) T cell responses to B. pertussis with age. PLoS One (2013) 0.83
Identification of human T-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun (1992) 0.82
Bordetella pertussis proteins dominating the major histocompatibility complex class II-presented epitope repertoire in human monocyte-derived dendritic cells. Clin Vaccine Immunol (2014) 0.82
Roads to the development of improved pertussis vaccines paved by immunology. Pathog Dis (2015) 0.81
Identification of murine T-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun (1993) 0.79
The effect of a single amino acid substitution within the V3 loop of HIV-1 gp120 on HLA-DR1-restricted CD4 T-cell recognition. Immunology (1995) 0.79
Identification of B-cell epitopes on the S4 subunit of pertussis toxin. Infect Immun (1993) 0.77
Genome-wide association study identifies SNPs in the MHC class II loci that are associated with self-reported history of whooping cough. Hum Mol Genet (2015) 0.75
Rediscovering Pertussis. Front Pediatr (2016) 0.75
Human antibody response to the B oligomer of pertussis toxin. Clin Diagn Lab Immunol (1994) 0.75
An overview of current Italian studies on bacterial pathogenesis. World J Microbiol Biotechnol (1992) 0.75
Pertussis immunisation and serious acute neurological illness in children. Br Med J (Clin Res Ed) (1981) 8.48
Nature and rates of adverse reactions associated with DTP and DT immunizations in infants and children. Pediatrics (1981) 7.58
Pertussis toxin gene: nucleotide sequence and genetic organization. Science (1986) 6.02
Direct modification of the membrane adenylate cyclase system by islet-activating protein due to ADP-ribosylation of a membrane protein. Proc Natl Acad Sci U S A (1982) 5.68
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A (1986) 5.59
Subunit structure of islet-activating protein, pertussis toxin, in conformity with the A-B model. Biochemistry (1982) 5.33
Development of a pertussis component vaccine in Japan. Lancet (1984) 3.94
An immunological study of the diphtheria toxin molecule. Immunochemistry (1972) 3.48
Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol (1987) 3.44
Pertussis toxin. Affinity purification of a new ADP-ribosyltransferase. J Biol Chem (1983) 3.31
Biological activities of crystalline pertussigen from Bordetella pertussis. Infect Immun (1981) 3.16
Monoclonal antibody against pertussis toxin: effect on toxin activity and pertussis infections. Infect Immun (1984) 2.59
Expression and immunological properties of the five subunits of pertussis toxin. Infect Immun (1987) 2.59
Dissecting human T cell responses against Bordetella species. J Exp Med (1988) 2.07
Protein antigenic structures recognized by T cells: potential applications to vaccine design. Immunol Rev (1987) 1.95
Epitopes of the cholera family of enterotoxins. Rev Infect Dis (1987) 1.91
ADP-ribosylation of transducin by islet-activation protein. Identification of asparagine as the site of ADP-ribosylation. J Biol Chem (1984) 1.83
The epidemiology of pertussis and pertussis immunization in the United Kingdom and the United States: a comparative study. Curr Probl Pediatr (1984) 1.81
Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity. Proc Natl Acad Sci U S A (1988) 1.61
Isolation and characterization of Ni-specific T cell clones from patients with Ni-contact dermatitis. J Immunol (1985) 1.59
ADP-ribosyltransferase activity of pertussis toxin and immunomodulation by Bordetella pertussis. Science (1988) 1.57
Pertussis in Sweden after the cessation of general immunization in 1979. Pediatr Infect Dis J (1987) 1.41
ADP-ribosyltransferase mutations in the catalytic S-1 subunit of pertussis toxin. Infect Immun (1988) 1.30
Human monoclonal antibodies to a genus-specific chlamydial antigen, produced by EBV-transformed B cells. J Immunol (1983) 1.10
MHC-restricted recognition of immunogenic T cell epitopes of pertussis toxin reveals determinants in man distinct from the ADP-ribosylase active site. J Exp Med (1988) 0.96
Trial of a new acellular pertussis vaccine in healthy adult volunteers. Vaccine (1988) 0.94
Immune suppression and induction of gamma interferon by pertussis toxin. Infect Immun (1985) 0.82
cag, a pathogenicity island of Helicobacter pylori, encodes type I-specific and disease-associated virulence factors. Proc Natl Acad Sci U S A (1996) 16.69
Complete genome sequence of Neisseria meningitidis serogroup B strain MC58. Science (2000) 16.04
Helicobacter pylori virulence and genetic geography. Science (1999) 7.64
Identification of vaccine candidates against serogroup B meningococcus by whole-genome sequencing. Science (2000) 7.41
Development of a mouse model of Helicobacter pylori infection that mimics human disease. Science (1995) 5.73
Cloning and sequencing of the pertussis toxin genes: operon structure and gene duplication. Proc Natl Acad Sci U S A (1986) 5.59
Junctional adhesion molecule, a novel member of the immunoglobulin superfamily that distributes at intercellular junctions and modulates monocyte transmigration. J Cell Biol (1998) 5.32
Nuclear factor TDP-43 and SR proteins promote in vitro and in vivo CFTR exon 9 skipping. EMBO J (2001) 5.23
Tyrosine phosphorylation of the Helicobacter pylori CagA antigen after cag-driven host cell translocation. Proc Natl Acad Sci U S A (2000) 5.07
Filamentous hemagglutinin of Bordetella pertussis: nucleotide sequence and crucial role in adherence. Proc Natl Acad Sci U S A (1989) 4.87
Sequences required for expression of Bordetella pertussis virulence factors share homology with prokaryotic signal transduction proteins. Proc Natl Acad Sci U S A (1989) 4.78
A pneumococcal pilus influences virulence and host inflammatory responses. Proc Natl Acad Sci U S A (2006) 4.40
Helicobacter pylori induced interleukin-8 expression in gastric epithelial cells is associated with CagA positive phenotype. J Clin Pathol (1995) 3.86
Bordetella parapertussis and Bordetella bronchiseptica contain transcriptionally silent pertussis toxin genes. J Bacteriol (1987) 3.44
DNA element of Corynebacterium diphtheriae with properties of an insertion sequence and usefulness for epidemiological studies. J Bacteriol (1987) 3.26
Living dangerously: how Helicobacter pylori survives in the human stomach. Nat Rev Mol Cell Biol (2001) 2.99
Mutants of pertussis toxin suitable for vaccine development. Science (1989) 2.89
Mutants of Escherichia coli heat-labile toxin lacking ADP-ribosyltransferase activity act as nontoxic, mucosal adjuvants. Proc Natl Acad Sci U S A (1995) 2.63
Families of bacterial signal-transducing proteins. Mol Microbiol (1989) 2.59
Expression and immunological properties of the five subunits of pertussis toxin. Infect Immun (1987) 2.59
Counterselectable markers: untapped tools for bacterial genetics and pathogenesis. Infect Immun (1998) 2.54
The complete nucleotide sequence of the gene coding for diphtheria toxin in the corynephage omega (tox+) genome. Nucleic Acids Res (1983) 2.51
Repeat-associated phase variable genes in the complete genome sequence of Neisseria meningitidis strain MC58. Mol Microbiol (2000) 2.44
Induction of interleukin-8 secretion from gastric epithelial cells by a cagA negative isogenic mutant of Helicobacter pylori. J Clin Pathol (1995) 2.37
Did the inheritance of a pathogenicity island modify the virulence of Helicobacter pylori? Trends Microbiol (1997) 2.33
Positive transcriptional feedback at the bvg locus controls expression of virulence factors in Bordetella pertussis. Proc Natl Acad Sci U S A (1990) 2.27
Bafilomycin A1 inhibits Helicobacter pylori-induced vacuolization of HeLa cells. Mol Microbiol (1993) 2.24
Cellular vacuoles induced by Helicobacter pylori originate from late endosomal compartments. Proc Natl Acad Sci U S A (1994) 2.19
Growth of Helicobacter pylori in media containing cyclodextrins. J Clin Microbiol (1993) 2.17
Low pH activates the vacuolating toxin of Helicobacter pylori, which becomes acid and pepsin resistant. J Biol Chem (1995) 2.17
The fibrinolytic receptor for urokinase activates the G protein-coupled chemotactic receptor FPRL1/LXA4R. Proc Natl Acad Sci U S A (2002) 2.14
Induction of antigen-specific antibodies in vaginal secretions by using a nontoxic mutant of heat-labile enterotoxin as a mucosal adjuvant. Infect Immun (1996) 2.14
Positive regulation of pertussis toxin expression. Proc Natl Acad Sci U S A (1988) 2.13
Characteristics of natural killer cells in the murine intestinal epithelium and lamina propria. J Exp Med (1982) 2.12
The small GTP binding protein rab7 is essential for cellular vacuolation induced by Helicobacter pylori cytotoxin. EMBO J (1997) 2.11
Structural and genetic analysis of the bvg locus in Bordetella species. Mol Microbiol (1991) 2.09
Up-regulation of IL-17 is associated with bioactive IL-8 expression in Helicobacter pylori-infected human gastric mucosa. J Immunol (2000) 2.08
Dissecting human T cell responses against Bordetella species. J Exp Med (1988) 2.07
Molecular and cellular signatures of human vaccine adjuvants. Proc Natl Acad Sci U S A (2008) 2.02
The neutrophil-activating protein (HP-NAP) of Helicobacter pylori is a protective antigen and a major virulence factor. J Exp Med (2000) 2.02
RrgA is a pilus-associated adhesin in Streptococcus pneumoniae. Mol Microbiol (2007) 2.01
Splicing factors induce cystic fibrosis transmembrane regulator exon 9 skipping through a nonevolutionary conserved intronic element. J Biol Chem (2000) 2.00
Evolutionary relationships in the genus Bordetella. Mol Microbiol (1987) 2.00
Helicobacter pylori second-line rescue therapy with levofloxacin- and bismuth-containing quadruple therapy, after failure of standard triple or non-bismuth quadruple treatments. Aliment Pharmacol Ther (2015) 1.99
Promoter of the pertussis toxin operon and production of pertussis toxin. J Bacteriol (1987) 1.98
Mucosal adjuvanticity and immunogenicity of LTR72, a novel mutant of Escherichia coli heat-labile enterotoxin with partial knockout of ADP-ribosyltransferase activity. J Exp Med (1998) 1.98
Histological findings of the internal inguinal ring in patients having indirect inguinal hernia. Hernia (2009) 1.98
Multimer formation and ligand recognition by the long pentraxin PTX3. Similarities and differences with the short pentraxins C-reactive protein and serum amyloid P component. J Biol Chem (1997) 1.97
The Fur repressor controls transcription of iron-activated and -repressed genes in Helicobacter pylori. Mol Microbiol (2001) 1.96
The m2 form of the Helicobacter pylori cytotoxin has cell type-specific vacuolating activity. Proc Natl Acad Sci U S A (1998) 1.95
Role of the Helicobacter pylori virulence factors vacuolating cytotoxin, CagA, and urease in a mouse model of disease. Infect Immun (1995) 1.93
Acute ischemic stroke and transient ischemic attack in the very old--risk factor profile and stroke subtype between patients older than 80 years and patients aged less than 80 years. Eur J Neurol (2007) 1.91
Mapping of murine Th1 helper T-Cell epitopes of mycolyl transferases Ag85A, Ag85B, and Ag85C from Mycobacterium tuberculosis. Infect Immun (2003) 1.91
Pertussis toxin export requires accessory genes located downstream from the pertussis toxin operon. Mol Microbiol (1993) 1.89
Selective increase of the permeability of polarized epithelial cell monolayers by Helicobacter pylori vacuolating toxin. J Clin Invest (1998) 1.89
Formation of anion-selective channels in the cell plasma membrane by the toxin VacA of Helicobacter pylori is required for its biological activity. EMBO J (1999) 1.88
Genetic characterization of Bordetella pertussis filamentous haemagglutinin: a protein processed from an unusually large precursor. Mol Microbiol (1990) 1.88
Natural and antibody-dependent cell-mediated activity against Salmonella typhimurium by peripheral and intestinal lymphoid cells in mice. J Immunol (1983) 1.82
Oligomeric and subunit structure of the Helicobacter pylori vacuolating cytotoxin. J Cell Biol (1996) 1.82
Introduction of unmarked mutations in the Helicobacter pylori vacA gene with a sucrose sensitivity marker. Infect Immun (1997) 1.82
Zika virus infection in a traveller returning to Europe from Brazil, March 2015. Euro Surveill (2015) 1.81
Burden of unidentifiable mycobacteria in a reference laboratory. J Clin Microbiol (2001) 1.79
Helicobacter pylori cytotoxin: importance of native conformation for induction of neutralizing antibodies. Infect Immun (1995) 1.79
Development and phase 1 clinical testing of a conjugate vaccine against meningococcus A and C. Vaccine (1992) 1.78
Proposal of an improved score method for the diagnosis of pulmonary tuberculosis in childhood in developing countries. Tuber Lung Dis (1992) 1.77
Bactericidal monoclonal antibodies that define unique meningococcal B polysaccharide epitopes that do not cross-react with human polysialic acid. J Immunol (1998) 1.75
Interferon-gamma reduces macrophage-suppressive activity by inhibiting prostaglandin E2 release and inducing interleukin 1 production. J Immunol (1984) 1.75
Probing the structure-activity relationship of Escherichia coli LT-A by site-directed mutagenesis. Mol Microbiol (1994) 1.75
Unravelling the pathogenic role of Helicobacter pylori in peptic ulcer: potential new therapies and vaccines. Trends Biotechnol (1994) 1.74
Sequential activation and environmental regulation of virulence genes in Bordetella pertussis. EMBO J (1991) 1.73
Morphological characterization of a cell population responsible for natural killer activity. Immunology (1981) 1.73
Increased levels of soluble P-selectin in hypercholesterolemic patients. Circulation (1998) 1.73
Natural killer activity of gut mucosal lymphoid cells in mice. Eur J Immunol (1981) 1.73
Helicobacter pylori: host responses in peptic ulceration. Lancet (1993) 1.73
Antibody-dependent cell-mediated antibacterial activity of intestinal lymphocytes with secretory IgA. Nature (1984) 1.71
Identification and characterization of an operon of Helicobacter pylori that is involved in motility and stress adaptation. J Bacteriol (1997) 1.70
Phase variants of Bordetella bronchiseptica arise by spontaneous deletions in the vir locus. Mol Microbiol (1989) 1.70
Chagas disease in European countries: the challenge of a surveillance system. Euro Surveill (2011) 1.69
Evaluation of the recombinant 38-kilodalton antigen of Mycobacterium tuberculosis as a potential immunodiagnostic reagent. J Clin Microbiol (1997) 1.69
Improving healthcare worker hand hygiene adherence before patient contact: a before-and-after five-unit multimodal intervention in Tuscany. Qual Saf Health Care (2009) 1.68
A genetically detoxified derivative of heat-labile Escherichia coli enterotoxin induces neutralizing antibodies against the A subunit. J Exp Med (1994) 1.68
Neisseria meningitidis group B correlates of protection and assay standardization--international meeting report Emory University, Atlanta, Georgia, United States, 16-17 March 2005. Vaccine (2006) 1.67
Restriction map of corynebacteriophages beta c and beta vir and physical localization of the diphtheria tox operon. J Bacteriol (1981) 1.67
Selective inhibition of Ii-dependent antigen presentation by Helicobacter pylori toxin VacA. J Exp Med (1998) 1.65
Characterization of mycobacterial isolates phylogenetically related to, but different from Mycobacterium simiae. J Clin Microbiol (1997) 1.64
The design of vaccines against Helicobacter pylori and their development. Annu Rev Immunol (2001) 1.61
Subunit S1 of pertussis toxin: mapping of the regions essential for ADP-ribosyltransferase activity. Proc Natl Acad Sci U S A (1988) 1.61
The amino-acid sequence of two non-toxic mutants of diphtheria toxin: CRM45 and CRM197. Nucleic Acids Res (1984) 1.60
Helicobacter pylori toxin VacA induces vacuole formation by acting in the cell cytosol. Mol Microbiol (1997) 1.60
Multi-frequency impedance for the prediction of extracellular water and total body water. Br J Nutr (1995) 1.57
Therapeutic intragastric vaccination against Helicobacter pylori in mice eradicates an otherwise chronic infection and confers protection against reinfection. Infect Immun (1997) 1.57
Integration of corynebacteriophages beta tox+, omega tox+, and gamma tox- into two attachment sites on the Corynebacterium diphtheriae chromosome. J Bacteriol (1983) 1.56
Cellular microbiology emerging. Science (1996) 1.56
Strategic priorities for respiratory syncytial virus (RSV) vaccine development. Vaccine (2013) 1.56
Tyrosine-phosphorylated bacterial proteins: Trojan horses for the host cell. J Exp Med (2000) 1.55